US 11117899
[1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitor
granted A61PA61P25/16A61P35/00
Quick answer
US patent 11117899 ([1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitor) held by Medshine Discovery Inc. expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Sep 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P25/16, A61P35/00, A61P43/00